Johnson Chemical Pharmaceutical Works Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 11, 2022
Share
Johnson Chemical Pharmaceutical Works Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 116.56 million compared to TWD 98.86 million a year ago. Net income was TWD 14.35 million compared to TWD 12.87 million a year ago. Basic earnings per share from continuing operations was TWD 0.48 compared to TWD 0.43 a year ago. Diluted earnings per share from continuing operations was TWD 0.48 compared to TWD 0.43 a year ago.
For the six months, sales was TWD 226.96 million compared to TWD 204.64 million a year ago. Net income was TWD 27.06 million compared to TWD 23.32 million a year ago. Basic earnings per share from continuing operations was TWD 0.9 compared to TWD 0.78 a year ago. Diluted earnings per share from continuing operations was TWD 0.9 compared to TWD 0.78 a year ago.
Johnson Chemical Pharmaceutical Works Co., Ltd. is a Taiwan-based company principally engaged in the manufacture and distribution of western medicines and the related raw materials. The Company mainly provides solid dosage forms, including soft and hard capsules, sugar coated tablets, film-coated tablets, suppositories, powder, granules, tablets and others. The Companyâs products include central nervous system drugs, hormones and hormone function medicines, respiratory medicines, gastrointestinal drugs, vitamins and others. The Company mainly distributes its products in Taiwan market and the rest of Asia.
JOHNSON CHEMICAL PHARMACEUTICAL WORKS CO., LTD. 
